Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 99.80 $ -0.74 (-0.74%)
Last Price 99.80 Change $ -0.74 Change % -0.74 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 99.76 High 99.80 Low 99.76 Prev Close 100.54
Last Trade Volume 400 52 Wk Hi 107.13 52 Wk Low 73.13
Market Cap 12 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 120,500,112.00 EPS (TTM) 1.36 PE Ratio 74.10 Exchange OTCPK